CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 38

Industry reads hand-picked by our editors

Aug 16, 2024

Bloomberg
Weight-Loss Drug Market to Lack Competition for Years, Zealand CEO Says
Endpoints News
Genentech dissolves cancer immunology group, and research executive Ira Mellman will leave company
CNBC
Bayer shares soar 11% after key U.S. legal win against Roundup cancer claims
STAT
The business of CRISPR’d medicine: Not great

Aug 15, 2024

The Financial Times
How Roche passed on a potential $14bn-a-year weight-loss pill
KFF Health News
Opioid Settlements Promise Mississippi a Windfall. What Happens Next?
BioCentury
No sleep for the biotech bear: Restructurings abound in August

Aug 14, 2024

Financial Times
AstraZeneca hits £200bn valuation
FirstWord Pharma
Rivus touts mid-stage win for muscle-preserving obesity candidate
C&EN
Will single-molecule protein sequencing be the next generation of proteomics?
Nature
Five ways science is tackling the antibiotic resistance crisis

Aug 13, 2024

Axios
Weight-loss drugs hit health care real estate
Fierce Pharma
Judge denies Novartis’ bid to block generic Entresto launch
Reuters
Biden targets tumors with $150 mln funding for ‘Cancer Moonshot’ program
Financial Times
NHS launches ‘subscription’ scheme for antibiotics with pharma sector

Aug 12, 2024

Reuters
US FDA extends review of Humacyte’s blood vessel implant
ApexOnco
Fresh questions over DLL3
AP News
FDA approves first nasal spray to treat dangerous allergic reactions
Fierce Biotech
Gilead pays J&J $320M to exit licensing deal for seladelpar

Aug 09, 2024

The 19th
IUD insertion is painful. For the first time, the CDC issued guidance for physicians.
Science
Bold new strategy to suppress HIV passes first
Bloomberg
23andMe’s Quarterly Sales Miss Estimates as CEO Seeks Control

Aug 08, 2024

MIT Technology Review
How covid conspiracy theories led to an alarming resurgence in AIDS denialism
Fierce Biotech
Lilly faces Phase 2 failure of tau-targeting med
FirstWord Pharma
BMS under FDA fire for misleading efficacy claims on Krazati website
Bloomberg
What Happens When Ozempic Takes Over Your Town

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Playbook
Navigating New Opportunities in China's Pharmaceutical Boom Custom content for Evaluate
Trendline
Inside the world of cell therapies Supported by 10x Genomics
Infographic
Accelerate clinical trials: Break silos, reduce delays Custom content for WCG

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
Peptides Under Pressure: Analytical Challenges in a High-Stakes Market Webinar - on demand • Provided by Solvias
Trends and Innovations in Life Science Qualitative Research Webinar - on demand • Provided by Konovo

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.